Top Industry Leaders in the Septic Arthritis Market
Latest Septic Arthritis Companies Update
Devicor Medical Products (US) Received FDA approval for its new SeptiFix joint drainage system, designed to improve joint fluid drainage and reduce infection risk.C. R. Bard (US) Announced the launch of its Bard Acessa II drainage catheter, specifically designed for safe and efficient joint fluid drainage in septic arthritis patients.Zimmer Biomet (US) Introduced its Persona Q™ Knee System with an injectable antibiotic spacer, offering a combination of joint replacement and targeted antibiotic delivery for treating infected knee joints.Merck & Co. (US) Received positive Phase III trial results for its investigational antibiotic, Zerxa (ceftaroline fosxil), demonstrating effective treatment of septic arthritis caused by gram positive bacteria.
List of Septic Arthritis Key companies in the market
- Lupin Pharmaceuticals, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Swtizerland)
- AbbVie Inc. (U.S.)
- Amgen Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Johnson & Johnson Inc. (U.S.)
- Pfizer (U.S.)